Abstract | OBJECTIVE: To evaluated the safety and effect of the 120-W GreenLight HPS laser photoselective vaporization of the prostate (PVP) in different BPH populations. METHODS: This study included 174 BPH patients treated by PVP using 120-W Green-Light HPS laser. According to the prostate volume (PV) ( < 80 or ≥ 80 ml), history of 5-alpha reductase inhibitor (5-ARI) medication, and history of acute urinary retention (AUR), we divided the patients into a PV < 80 ml, a PV ≥ 80 ml, a 5-ARI, a no 5-ARI; an AUR, and a no AUR group. We collected the baseline, perioperative, and follow-up data about the patients, and compared them among different groups. RESULTS: The patients were aged 69.4 ± 7.7 years, of whom PVP was successfully performed for 136 and PVP was intraoperatively converted to transurethral resection of the prostate ( TURP) in the other 38, with a mean operation time of (49.4 ± 16.3) min. The preoperative PV averaged (67.9 ± 29.8) ml. There was no intraoperative blood transfusion, transurethral resection syndrome, or capsule perforation. Bladder neck contracture occurred in 2 cases and urethral stricture developed in another 2 postoperatively. All the patients showed a significant improvement in the prostatic function parameters and no significant differences were observed between the PV < 80 ml and PV ≥ 80 ml, 5-ARI and no 5-ARI, or AUR and no AUR groups. CONCLUSION: PVP with 120-W GreenLight HPS laser is safe and efficient for the treatment of BPH and the its effect is not influenced by the prostate volume, history of 5-ARI medication, or history of AUR. However, preoperative urinary catheterization may increase the difficulty of surgery and the risk of conversion to TURP.
|
Authors | Kun Fang, Bo Yang, Rui Qu, Qiang Dong |
Journal | Zhonghua nan ke xue = National journal of andrology
(Zhonghua Nan Ke Xue)
Vol. 21
Issue 7
Pg. 619-25
(Jul 2015)
ISSN: 1009-3591 [Print] China |
PMID | 26333224
(Publication Type: Journal Article)
|
Chemical References |
- 5-alpha Reductase Inhibitors
|
Topics |
- 5-alpha Reductase Inhibitors
(therapeutic use)
- Aged
- Humans
- Laser Therapy
(adverse effects, methods)
- Male
- Operative Time
- Organ Size
- Prostate
(pathology, surgery)
- Prostatic Hyperplasia
(pathology, surgery)
- Transurethral Resection of Prostate
- Treatment Outcome
- Urethral Stricture
(etiology)
- Urinary Bladder
- Urinary Retention
|